High cholesterol levels affect mobilization of cells from the bone marrow

May 10, 2010

Increased cholesterol levels are being increasingly recognised as risk factors for the onset and progression of several cancers. Now researchers in Portugal show that high levels of cholesterol can affect the microenvironment of the bone marrow, so that more cells move from the bone marrow to peripheral, circulating blood. These findings, by Sergio Dias and his team, an external group of the Instituto Gulbenkian de Ciência, have implications for transplantation and further understanding bone marrow malignancies, are to appear in the next issue of the journal Blood.

Progenitors of blood cells develop in the bone marrow, where they mature in specific microenvironments, called niches, before exiting into peripheral blood, in a highly controlled fashion. It is well established that external stimuli affect these niches and therefore the production of mature blood cells. For example, patients with high cholesterol levels (hypercholesterolemia) have more peripheral blood cells and increased platelet levels (thrombocytosis). Working at the Portuguese Institute of Oncology Francisco Gentil, in Lisbon, the Neoangiogenesis group used a mouse model of hypercholesterolemia to show that cholesterol interferes with the bone marrow niche equilibrium, thus leading to increased exit from the bone marrow niche to the peripheral circulation.

These finding may have implications for transplants and bone marrow malignances. As Sérgio Dias points out "It is the first time, as far as we are aware, that cholesterol is directly linked to mobilisation of cells in the bone marrow. In a transplant setting, we believe patients with high cholesterol may be less 'receptive', since more blood cells exit to the peripheral vessels. Therefore drugs that modulate cholesterol levels may have beneficial effects also in a transplant setting."

"Furthermore, as cholesterol empties cells from the bone marrow microenvironment, we envisage that it may create more space for malignant leukaemia cells to come into the bone marrow, thus favoring acute leukaemia expansion and spread to secondary organs", this group leader adds.
This study was carried out with support from the Portuguese national funding agency, Fundação para a Ciência e a Tecnologia (FCT) and GlaxoSmithKline.

Instituto Gulbenkian de Ciencia

Related Cholesterol Articles from Brightsurf:

Cholesterol's effects on cellular membranes
The findings have far-reaching implications in the general understanding of disease, the design of drug delivery methods, and many other biological applications that require specific assumptions about the role of cholesterol in cell membranes.

Autism-cholesterol link
Study identifies genetic link between cholesterol alterations and autism.

Microbes might manage your cholesterol
Researchers discover a link between human blood cholesterol levels and a gene in the microbiome that could one day help people manage their cholesterol through diet, probiotics, or entirely new types of treatment.

Experimental cholesterol-lowering drug effective at lowering bad cholesterol, study shows
Twice-yearly injections of an experimental cholesterol-lowering drug, inclisiran, were effective at reducing low-density lipoprotein (LDL) cholesterol, often called bad cholesterol, in patients already taking the maximum dose of statin drugs, according to data of the ORION-10 trial presented Saturday, Nov.

Rethinking how cholesterol is integrated into cells
Cholesterol is best known in connection with cardiovascular disease, but cholesterol is also vital for many fundamental processes in the body.

Seed oils are best for LDL cholesterol
Using a statistical technique called network meta-analysis, researchers have combined the results of dozens of studies of dietary oils to identify those with the best effect on patients' LDL cholesterol and other blood lipids.

Cholesterol leash: Key tethering protein found to transport cellular cholesterol
Cholesterol is an essential component of living organisms, but the mechanisms that transport cholesterol inside the cell are poorly understood.

New way to treat cholesterol may be on the horizon
A breakthrough discovery by scientists at Houston Methodist Research Institute could change the way we treat cholesterol.

How low should LDL cholesterol go?
New analysis shows that in a high-risk population, achieving ultra-low LDL cholesterol levels, down to <10 mg/dL, safely results in additional lowering of risk of cardiovascular events.

Does boosting 'good' cholesterol really improve your health?
A new review addresses the mysteries behind 'good' HDL cholesterol and why boosting its levels does not necessarily provide protection from cardiovascular risk for patients.

Read More: Cholesterol News and Cholesterol Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.